Search details
1.
Immunologic predictors of vaccine responsiveness in patients with lymphoma and CLL.
J Infect Dis
; 2024 Mar 04.
Article
in English
| MEDLINE | ID: mdl-38437622
2.
CAR T cell viability release testing and clinical outcomes: is there a lower limit?
Blood
; 134(21): 1873-1875, 2019 11 21.
Article
in English
| MEDLINE | ID: mdl-31554634
3.
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma.
Transplant Cell Ther
; 2024 Mar 16.
Article
in English
| MEDLINE | ID: mdl-38494076
4.
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel.
J Hematol Oncol
; 17(1): 19, 2024 Apr 22.
Article
in English
| MEDLINE | ID: mdl-38644469
5.
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Nat Med
; 30(4): 984-989, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38266761
6.
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines.
Blood Adv
; 8(3): 653-666, 2024 02 13.
Article
in English
| MEDLINE | ID: mdl-38113468
Results
1 -
6
de 6
1
Next >
>>